National and Kapodistrian University of Athens
Προγνωστικοί και προβλεπτικοί της θεραπείας παράγοντες σε όγκους αρχέγονων γεννητικών κυττάρων
Abstract
dc:descriptionGerm cell tumors and especially testicular cancer is the most common malignancy in young male 20-35 years old. Recent advances are oriented in risk prediction models, in order to identify poor risk patients that will not respond to chemotherapy, or relapse, candidates for intense chemotherapeutic regimens, and good risk patients that minimal toxicity is the point. The identification, at a molecular level, of factors or pathways that may have prognostic value on the efficacy of chemotherapy and therefore on survival, is crucial in order to rationalize treatment success. The aim of this study is to assess the prognostic significance of immunohistochemical markers that correlate with cellular proliferation and growth (p53, MIB-1, c-KIT), cellular death (p53, bax, bcl-2), angiogenesis (COX-2) and chemoresistance (topoisomerase IIa, p53). One hundred seventy-seven patients with the diagnosis of germ cell tumor and paraffin embedded tissue available are included in the study. The mean age of the population was 28 years (range 16-75 years). According to the IGCCCG classification, 129 patients were good risk, 28 were intermediate risk and 20 were poor risk. From the studied markers, p53 (HR 4.01, 95% CI 1.25-12.84, p=0.019) and MIB-1 (HR 3.16, 95% CI 1.06-9.45, p=0.039) were associated with overall survival. The best cut-off values were 10% for p53 and 30% for ΜΙΒ-1, with specificity of 75-85% and sensitivity of 50-60%. The combination of the two markers was correlated with the pathological stage, the primary site and the IGCCCG classification. Multivariate analysis, including all the above mentioned parameters plus chemotherapy regimen showed that the immunohistochemical combination (HR 6.63, 95% CI 1.40-31.41, p=0.017) and the IGCCCG classification (HR 7.99, 95% CI 1.96-32.52, p=0.004) are independently associated with survival. Conclusively, the combination of p53 and MIB-1 could be used in conjunction with the IGCCCG classification for more accurately defining risk in germ cell cancer patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nikolaou, Maria
- Νικολάου, Μαρία
Subjects
dc:subject × 16- Όγκοι αρχέγονων γεννητικών κυττάρων
- Καρκίνος όρχεων
- Ανοσοϊστοχημικοί δείκτες
- Πρόγνωση
- Μη σεμινωματώδεις όγκοι
- Germ cell tumours
- Testicular cancer
- Immunohistochemistry
- p53
- Mib-1
- Prognostic markers
- Non seminomatous tumours
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27856